Literature DB >> 17694372

Influence of atrial natriuretic peptide, brain natriuretic peptide and urodilatin on the histamine-induced bronchoconstriction in the conscious guinea pig.

M Hermel1.   

Abstract

The influence of human atrial natriuretic peptide (ANP) and of two related peptides, human brain natriuretic peptide (BNP) and urodilatin (URO) on the bronchoconstriction induced by inhalation of histamine in conscious, non-anaesthetized guinea pigs was tested.Changes in lung function were registered using two independent methods, one operating in a closed body-plethysmographic system, the other in an open system based on the time lag of air flow curves. The peptides were infused (0.25 ml/min) into the jugular vein for a period from 10 min before until 15 min after the histamine inhalation.ANP displayed virtually no effect on the bronchoconstriction. URO showed some inibition at 1280ng kg(-1) min(-1), but not at lower doses. BNP (640ng kg(-1) min(-1)) inhibited the bronchoconstriction markedly for the total registration period.It can be concluded from these results that BNP exerts bronchoprotective effects in the conscious guinea pig, which are superior to those of ANP or URO.

Entities:  

Year:  1998        PMID: 17694372     DOI: 10.1007/s10787-998-0032-2

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   5.093


  96 in total

1.  Bronchodilator effect of atrial natriuretic peptide in asthma.

Authors:  G Hulks; A Jardine; J M Connell; N C Thomson
Journal:  BMJ       Date:  1989-10-28

2.  Involvement of sympathetic nerves in cardiosuppressive effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) in anesthetized rats.

Authors:  A Sasaki; O Kida; K Kangawa; H Matsuo; K Tanaka
Journal:  Eur J Pharmacol       Date:  1986-01-29       Impact factor: 4.432

3.  Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content.

Authors:  N Katsube; D Schwartz; P Needleman
Journal:  J Pharmacol Exp Ther       Date:  1986-11       Impact factor: 4.030

4.  A noninvasive technique for measurement of changes in specific airway resistance.

Authors:  B E Pennock; C P Cox; R M Rogers; W A Cain; J H Wells
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-02

5.  Bronchoprotective and bronchodilator activity of anaritide (human atrial natriuretic factor [102-126]) infusion in the anesthetized guinea pig.

Authors:  I M Englebach; R W Lappe; J M Hand
Journal:  Pulm Pharmacol       Date:  1988

6.  Clearance function of type C receptors of atrial natriuretic factor in rats.

Authors:  F A Almeida; M Suzuki; R M Scarborough; J A Lewicki; T Maack
Journal:  Am J Physiol       Date:  1989-02

7.  Atrial natriuretic factor can increase renal solute excretion primarily by raising glomerular filtration.

Authors:  M G Cogan
Journal:  Am J Physiol       Date:  1986-04

8.  Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats.

Authors:  F C Luft; R E Lang; G R Aronoff; H Ruskoaho; M Toth; D Ganten; R B Sterzel; T Unger
Journal:  J Pharmacol Exp Ther       Date:  1986-02       Impact factor: 4.030

9.  Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Authors:  S Suga; K Nakao; K Hosoda; M Mukoyama; Y Ogawa; G Shirakami; H Arai; Y Saito; Y Kambayashi; K Inouye
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

10.  Central effects of somatostatin and atrial natriuretic peptide on tracheal tone.

Authors:  M A Haxhiu; E C Deal; E Van Lunteren; N S Cherniack
Journal:  J Appl Physiol (1985)       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.